STREAMLINE HEALTH SOLUTIONS INC. STRM Cash Flow

Streamline health solutions inc. (STRM)

CashFlow / TTM

Jan'20	Oct'19	Jul'19	Apr'19	Jan'19	Oct'18	Jul'18	Apr'18	Jan'18	Oct'17	Jul'17	Apr'17	Jan'17	Oct'16	Jul'16	Apr'16	Jan'16	Oct'15	Jul'15	Apr'15	Jan'15	Oct'14	Jul'14	Apr'14	Jan'14	Oct'13	Jul'13	Apr'13	Jan'13	Oct'12	Jul'12	Apr'12	Jan'12	Oct'11	Jul'11	Apr'11
Cash flows from operating activities:
Net loss
-2,863	-3,556	-4,069	-4,983	-5,865	-2,729	-2,049	-1,625	-3,099	-4,156	-6,090	-5,726	-5,161	-5,545	-4,071	-3,901	-4,290	-7,696	-9,495	-11,206	-12,011	-9,148	-13,125	-11,678	-11,717	-17,577	-8,945	-8,580	-5,378	2,432	328	784	12	0	0	0
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation
137	152	201	314	450	589	695	742	774	800	872	982	1,099	1,210	1,250	1,251	1,245	1,264	1,269	1,168	1,005	899	741	697	718	670	701	718	726	0	0	0	-	-	-	-
Amortization of capitalized software development costs
1,458	909	931	1,051	1,160	1,433	1,615	1,856	2,113	2,199	2,489	2,627	2,771	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of capitalized software development costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of capitalized software development costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,799	-2,659	0	0	0	-	-	-	-
Amortization of intangible assets
554	656	752	845	937	943	964	1,062	1,161	1,291	1,360	1,352	1,344	1,309	1,321	1,333	1,344	1,356	1,365	1,374	1,396	1,446	1,417	1,386	1,341	1,272	1,187	806	583	0	0	0	-	-	-	-
Amortization of other deferred costs
480	276	323	361	415	458	407	360	341	361	370	364	324	257	238	208	206	159	170	209	189	261	301	341	385	310	388	304	241	0	0	0	-	-	-	-
Valuation adjustment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,326	2,411	2,283	4,549	3,035	1,924	140	-1,593	-1,180	-155	489	0	0	0	-	-	-	-
Valuation adjustments
64	103	101	90	126	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other valuation adjustments
-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	0	0	-	-	-	-	-	-	-	-
Loss on disposal of fixed assets
-	-	-	-	-7	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Loss from early extinguishment of debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-26	0	0	0
Share-based compensation expense
934	856	691	676	629	756	920	1,063	1,109	1,289	1,433	1,577	1,787	1,870	2,012	2,211	2,386	2,506	2,352	2,143	1,934	1,742	1,700	1,636	1,660	1,514	1,381	1,245	956	1,011	899	876	894	0	0	0
Accounts receivable provision (reversal)
-201	-88	-48	-256	13	28	3	38	234	166	198	236	121	249	123	116	124	199	516	521	441	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Deferred tax benefit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Changes in assets and liabilities:
Accounts and contract receivables
-818	-224	166	-155	640	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Accounts and contract receivables
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-827	-938	7,455	4,652	2,923	3,257	-412	760	1,485	0	0	0
Other assets
392	378	197	-315	-466	-247	257	555	696	352	-330	-390	-449	-294	-41	-190	-575	-88	-536	-636	637	126	1,065	952	439	1,274	706	1,057	1,129	440	575	324	47	0	0	0
Accounts payable
-10	-841	137	-103	859	662	-775	468	-695	-281	802	276	-51	309	-1,949	-1,149	-1,117	-1,315	91	207	600	598	1,122	901	275	750	784	-396	526	-96	-152	330	202	0	0	0
Accrued expenses
-412	-367	-1,059	-1,324	129	-197	822	122	-117	258	-569	-27	-690	-925	-370	-336	-174	-684	-917	-1,161	-1,422	-391	524	514	259	-105	-650	562	992	1,210	1,075	343	-311	0	0	0
Deferred revenues
-725	-165	-505	289	-2,004	-980	-1,466	-557	-671	-414	-404	88	-341	-1,830	-1,113	-313	1,405	1,369	1,742	500	-197	406	-561	-715	-152	-3,745	1,177	343	-180	3,516	275	471	730	0	0	0
Net cash (used in) provided by operating activities
-8	1,130	1,010	2,153	1,397	2,651	3,472	3,522	2,031	923	-96	2,012	1,008	683	5,209	4,480	5,880	3,304	2,071	-126	-3,011	-2,911	-2,693	-1,022	212	-1,821	-4,650	-4,450	-115	4,739	5,354	4,750	2,896	0	0	0
Cash flows from investing activities:
Purchases of property and equipment
52	51	53	56	21	45	53	43	49	29	455	503	506	776	461	514	518	505	606	1,548	2,125	1,908	1,693	666	152	137	222	427	576	708	620	478	408	0	0	0
Proceeds from sales of property and equipment
-	-	-	-	21	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capitalization of software development costs
3,358	3,445	3,352	3,247	3,003	2,787	2,520	2,175	1,836	1,895	1,886	1,867	1,978	1,420	936	497	0	116	268	426	619	69	167	347	614	1,476	1,827	1,952	1,999	2,201	2,179	2,322	2,600	0	0	0
Payment for acquisition, net of cash received
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-
Net cash used in investing activities
-3,410	-3,495	-3,398	-3,296	-3,003	-2,792	-2,539	-2,184	-1,865	75	-1,742	-1,770	-1,884	-3,596	-1,398	-1,012	-518	-621	-1,042	-2,142	-8,803	-8,036	-10,751	-9,903	-3,766	-4,613	-14,211	-14,541	-14,738	-17,196	-4,924	-4,924	-5,132	0	0	0
Cash flows from financing activities:
Principal payments on term loan
4,030	597	597	597	597	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments related to settlement of employee shared-based awards
99	50	35	15	62	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net change under revolving credit facility
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Proceeds from exercise of stock options and stock purchase plan
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-
Principal repayments on term loans
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10,229	10,238	10,348	1,250	937	625	312	0	0	0	-	-	-	-
Principal payments on capital lease obligations
-	-	-	-	-	-	-	-	91	124	198	385	569	749	851	833	815	805	722	543	368	0	0	0	-	-	0	0	-	-	-	-	183	0	0	0
Proceeds from exercise of stock options and stock purchase plan
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	276	339	709	694	552	2,887	2,145	1,418	1,356	-648	-377	221	282	0	0	0	-	-	-	-
Recovery of deferred financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Payment of deferred financing costs
-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	115	0	0	0	-	-	-	-	-	-	-	-
Net cash provided by (used in) financing activities
2,691	2,441	371	-594	-638	-607	-602	-1,169	-1,200	-1,646	-1,758	-3,180	-3,351	-3,051	-3,329	-2,221	-2,002	-121	-153	572	412	12,628	13,245	13,890	13,978	170	20,145	19,859	20,110	22,685	3,063	2,826	3,075	0	0	0
Net decrease in cash and cash equivalents
-	-	-	-1,737	-	-	-	168	-1,034	-648	-3,596	-2,938	-4,228	-5,965	482	1,246	3,359	2,560	875	-1,696	-11,402	1,680	-199	2,964	10,424	-6,264	1,284	867	5,257	10,228	3,493	2,652	839	0	0	0
Supplemental cash flow disclosures:
Interest paid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	92	0	0	0
Supplemental disclosure of non-cash financing activities:
Income taxes (received) paid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	20	0	0	0